Marathi
|
Hindi
Download App
Epaper
Home
City
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Chhatrapati Sambhajinagar
Nagpur
Entertainment
Photos
Business
Technology
Sports
Lifestyle
Social Viral
Lokmat Games
Health
City
Home
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Nagpur
Chhatrapati Sambhajinagar
Trending Topics :
Lok Sabha Election 2024
Heatwave In India
Mumbai Water Cut
Maharashtra Lok Sabha Election
IPL 2024
Salman Khan
All
News
Photos
Videos
Glenmark Pharmaceuticals Ltd
FOLLOW
Glenmark pharmaceuticals ltd, Latest News
Health :
Glenmark gets USFDA approval for Clindamycin Phosphate Foam 1%
Chennai, Sep 21 Pharma major Glenmark Pharmaceuticals Ltd on Tuesday said it has received final approval by the ... ...
Business :
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Foam, 1%
Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin Phosphate Foam, 1%, the generic version of Evoclin®1 Foam, 1%, of Mylan Pharmaceuticals Inc. ...
Business :
Glenmark concludes post marketing surveillance (PMS) study on Favipiravir (FabiFlu®)
Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced the successful completion of its Post Marketing Surveillance (PMS) study on Favipiravir (FabiFlu®) in India. ...
National :
Glenmark's post-marketing surveillance shows no safety concerns on use of Favipiravir for COVID-19
The Glenmark Pharmaceuticals' post-marketing surveillance (PMS) study has shown no safety concerns with the use of Favipiravir (FabiFlu®[?]) in India for COVID-19 infection. ...
National :
Glenmark's post-marketing surveillance shows no safety concerns on use of Favipiravir for COVID-19
The Glenmark Pharmaceuticals' post-marketing surveillance (PMS) study has shown no safety concerns with the use of Favipiravir (FabiFlu®[?]) in India for COVID-19 infection. ...
Business :
Fitch affirms Glenmark Pharmaceuticals at BB on IPO of API business
Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating at BB after its active pharmaceutical ingredient (API) business completed an initial public offering (IPO). ...
Health :
Glenmark to make, market SaNOtize's nasal spray against Covid-19
Chennai, Aug 2 Pharma major Glenmark Pharmaceuticals Ltd on Monday said it has signed a long term partnership ... ...
Business :
Glenmark, Canada's SaNOtize to commercialise nasal spray for Covid-19 treatment
Glenmark Pharmaceuticals and Canadian biotech firm SaNOtize Research and Development Corp on Monday announced an exclusive long term strategic partnership to manufacture, market and distribute nitric oxide nasal spray (NONS) for Covid-19 treatment in ...
Previous Page
Next Page